Thymosin alpha-1 activated tumor-associated macrophages (TAMs) to become tumoricidal, converting these normally immunosuppressive cells into cancer-killing effectors — a mechanism for overcoming the tumor microenvironment.
Key findingThymosin alpha-1 reprogrammed tumor-associated macrophages from immunosuppressive to tumoricidal phenotype, enabling them to kill cancer cells directl
What the researchers found
Thymosin alpha-1 reprogrammed tumor-associated macrophages from immunosuppressive to tumoricidal phenotype, enabling them to kill cancer cells directly — overcoming a key immune evasion mechanism of the tumor microenvironment.
Why it matters
Relevant for thymosin-alpha-1, cancer, immune-function.
How the study worked
animal-study study on thymosin-alpha-1, cancer.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2004.
The bigger picture
Advances peptide therapeutics research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Activation of tumor-associated macrophages by thymosin alpha 1.
International journal of immunopathology and pharmacology, 17(1), 39-47
Citation
Shrivastava, P; Singh, S M; Singh, N. (2004). Activation of tumor-associated macrophages by thymosin alpha 1.. International journal of immunopathology and pharmacology, 17(1), 39-47.